Boston, MA 10/03/2014 (wallstreetpr) – Hundreds of people died due to Ebola over the past few months in Arabian and African Countries. Many companies tried to come up with a permanent solution of this virus without any success. Ebola is once again in news, so is Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR). As soon as two fresh cases of Ebola were found in the U.S., the talks about its deathly show in African countries started. Amidst all this, Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) surged by massive growth rate of 27% over the past few days. Reason is very simple, as it announced sometime back that it had come up with Ebola treatment. Currently, it is the only company, which has come up with a treatment for this deadly virus. As per the announcement made by TKMR on September 22, 2014, its TKM-EBOLA had been given emergency approval to be used in West Africa.
Overview of past few days and change in target price:
Right after the approval in West Africa, Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) also announced that it would join the international consortium at earliest in order to establishing clinic development centers in Ebola hot zones. Even though, TKMR was trending in share markets since the time it got approval in West Africa, but after the announcement of fresh cases in Texas, its shares have touched unbelievable heights. After the recent news, the company had increased its price target from $23 to $31, which is something nobody gets to see within a matter of few days time. It reported Ebola treatment success rate of 60%-80% in clinical trials on monkeys, which gave further hopes of its success in humans as well.
There is no other option available apart from exercising Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)’s Ebola treatment as of now. The question that strikes in minds of many is that will it be able to sustain the eye-catching growth that it has got over the past few days or not?
The shares of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) has jumped as much as 15.12% in today’s trading session and is now hovering around $29.35.